Scientists overturned a key assumption in aging research by showing that some senescent or zombie cells actually protect the body rather than exclusively causing damage.
Senescent cells halt division and secrete signaling molecules long thought to drive inflammation and tissue decline. New data indicate certain subsets may stabilize tissue structure or facilitate wound healing under specific conditions.
Therapies aiming to clear all senescent cells may therefore require refinement to avoid removing beneficial populations. Drug developers pursuing senolytics said precision targeting becomes more important given dual roles.
Aging biologists plan experiments to classify senescent cell types using single-cell genomics. The revised model could explain why some senolytic trials produced mixed results in muscle and brain tissues.
Ethicists noted implications for anti-aging marketing claims that portray senescent cells uniformly as harmful. Peer review continues as independent labs attempt to replicate protective phenotypes observed in the study.
Some senescent zombie cells protect tissue rather than only causing damage, overturning a core aging research assumption. Senolytic therapies may need precision targeting to avoid removing beneficial cells.
Biotech firms developing senolytics said they will stratify cell types before human trials proceed. Gerontology journals invited commentaries on revising theories that treated all senescent cells as harmful.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/